CIK 0001720580
- Non-accelerated filer
- Smaller reporting company
Adicet Bio, Inc.
Sign in to watch- Ticker
- ACET
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 26
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813305277
- Phone
- +1 617-482-2333
- Business address
- 131 DARTMOUTH STREET, 3RD FLOOR, BOSTON, MA, 02116
- Former names
- resTORbio, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-12-06 | Klickstein Lloyd Chief Innovation Officer | Grant or award | −16,888 | 16,888 | ||
| 2019-12-06 | Mannick Joan Chief Medical Officer | Grant or award | +118,222 | 1,404,585 | ||
| 2019-12-06 | Mannick Joan Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +88,667 | 88,667 | ||
| 2019-12-06 | MCCABE JOHN J Vice President, Finance | Grant or award | +12,867 | 12,867 | ||
| 2019-12-06 | MCCABE JOHN J Vice President, Finance | Grant or award · Stock Option (Right to Buy) | +16,400 | 16,400 | ||
| 2019-12-06 | Klickstein Lloyd Chief Scientific Officer | Grant or award | +118,222 | 118,222 | ||
| 2019-12-06 | Klickstein Lloyd Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +88,667 | 88,667 | ||
| 2019-12-06 | Schor Chen President and CEO | Grant or award | +344,000 | 669,000 | ||
| 2019-12-06 | Schor Chen President and CEO | Grant or award · Stock Option (Right to Buy) | +258,000 | 258,000 | ||
| 2019-11-15 | PureTech Health LLC 10% owner | Sale | −531,040 | $1.25 | $662K | 9,269,356 |
| 2019-05-13 | Klickstein Lloyd Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +295,000 | 295,000 | ||
| 2019-05-08 | Sullivan Lynne Marie Director | Grant or award · Stock Option (Right to Buy) | +14,414 | 14,414 | ||
| 2019-05-08 | SILVERSTEIN JONATHAN Director | Grant or award · Stock Option (Right to Buy) | +14,414 | 14,414 | ||
| 2019-05-08 | Grissinger Michael Director | Grant or award · Stock Option (Right to Buy) | +14,414 | 14,414 | ||
| 2019-05-08 | Chodakewitz Jeffrey Director | Grant or award · Stock Option (Right to Buy) | +14,414 | 14,414 | ||
| 2019-05-08 | FONTEYNE PAUL R. Director | Grant or award · Stock Option (Right to Buy) | +14,414 | 14,414 | ||
| 2019-05-08 | Steinberg David Adam Director | Grant or award · Stock Option (Right to Buy) | +14,414 | 14,414 | ||
| 2019-02-27 | Mannick Joan Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +93,000 | 93,000 | ||
| 2019-02-27 | Schor Chen President and CEO | Grant or award · Stock Option (Right to Buy) | +214,000 | 214,000 | ||
| 2019-02-27 | Manning Meredith Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +26,000 | 26,000 |
Page 27 of 29 · 569 trades